Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Dec;87(12):481-7.

The prevalence, clinical features, risk factors and outcome associated with cryptococcal meningitis in HIV positive patients in Kenya

Affiliations

The prevalence, clinical features, risk factors and outcome associated with cryptococcal meningitis in HIV positive patients in Kenya

R Mdodo et al. East Afr Med J. 2010 Dec.

Abstract

Objectives: To determine the prevalence, clinical features, risk factors and outcomes associated with cryptococcal meningitis (CM) in human immunodeficiency virus (HIV) positive patients at two referral hospitals in Nairobi, Kenya.

Design: Prospective, observational study.

Setting: Kenyatta National Hospital (KNH) and Mbagathi District Hospital (MDH), Nairobi, Kenya.

Subjects: Three hundred and forty HIV patients presenting with suspected CM.

Results: Of three hundred and forty suspected CM patients, 111 (33%) were diagnosed with CM by CrAg. Among CM patients, in-hospital mortality was 36% (38/106), median age was 35 years (range, 19-60 years) and median CD4 count was 41 cells/microL (n = 89, range 2-720 cells/microL). Common clinical manifestations among CM patients included headache 103 (93%), neck stiffness 76 (69%) and weight loss 53 (48%). Factors independently associated with CM were male sex, headache, blurred vision and previous antifungal drug use. Night sweats and current use of anti-retroviral therapy were associated with reduced risk for CM.

Conclusions: There is a high prevalence of CM and CM-associated mortality in HIV patients at KNH and MDH despite treatment with antifungal and anti-retroviral drugs. This study demonstrates the need to address the existing inadequacies of CM patient outcomes in Kenya.

PubMed Disclaimer

References

    1. UNAIDS. Report on Global AIDS Epidemic 2008. Geneva: 2008.
    1. National AIDS and STI Control Programme. Preliminary Report. Nairobi: 2007. Kenya AIDS Indicator Survey.
    1. McCarthy K, Morgan J, Wannemuehler K, Mirza S, et al. Population-based surveillance for cryptococcosis in an antiretroviral-naïve South African province with high HIV seroprevalence. AIDS. 20:2199–2206. - PubMed
    1. Jowi J, Mativo P, Musoke S. Clinical and laboratory characteristics of hospitalized patients with neurological manifestations of HIV/AIDS at the Nairobi hospital. East Afr Med J. 2007;84:67–76. - PubMed
    1. Hakim J, Gangaidzo I, Heyderman R, et al. Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients. AIDS. 2000;14:1401–1407. - PubMed